Comparative study of HOCl-inflicted damage to bacterial DNA ex vivo and within cells.
The prospects for using bacterial DNA as an intrinsic probe for HOCl and secondary oxidants/chlorinating agents associated with it has been evaluated using both in vitro and in vivo studies. Single-strand and double-strand breaks occurred in bare plasmid DNA that had been exposed to high levels of HOCl, although these reactions were very inefficient compared to polynucleotide chain cleavage caused by the OH.-generating reagent, peroxynitrite. Plasmid nicking was not increased when intact Escherichia coli were exposed to HOCl; rather, the amount of recoverable plasmid diminished in a dose-dependent manner. At concentration levels of HOCl exceeding lethal doses, genomic bacterial DNA underwent extensive fragmentation and the amount of precipitable DNA-protein complexes increased several-fold. The 5-chlorocytosine content of plasmid and genomic DNA isolated from HOCl-exposed E. coli was also slightly elevated above controls, as measured by mass spectrometry of the deaminated product, 5-chlorouracil. However, the yields were not dose-dependent over the bactericidal concentration range. Genomic DNA recovered from E. coli that had been subjected to phagocytosis by human neutrophils occasionally showed small increases in 5-chlorocytosine content when compared to analogous cellular reactions where myeloperoxidase activity was inhibited by azide ion. Overall, the amount of isolable 5-chlorouracil from the HOCl-exposed bacterial cells was far less than the damage manifested in polynucleotide bond cleavage and cross-linking.
Department of Chemistry, Washington State University, Pullman, WA 99164-4630, USA.
Christine
C
Suquet
Jeffrey J
JJ
Warren
Nimulrith
N
Seth
James K
JK
Hurst
D001386:Azides / Q000494:pharmacology; D053904:DNA Breaks, Single-Stranded; D053938:DNA Fragmentation; D004269:DNA, Bacterial / Q000378:metabolism* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D048168:Escherichia coli K12; D006801:Humans; D006997:Hypochlorous Acid / Q000378:metabolism* / Q000494:pharmacology; D009504:Neutrophils / Q000378:metabolism*; D016877:Oxidants / Q000378:metabolism / Q000494:pharmacology; D009195:Peroxidase / Q000037:antagonists & inhibitors / Q000378:metabolism; D030421:Peroxynitrous Acid / Q000494:pharmacology; D010587:Phagocytosis / Q000187:drug effects; D010957:Plasmids / Q000378:metabolism / Q000494:pharmacology; D014498:Uracil / Q000031:analogs & derivatives* / Q000378:metabolism
D001386:Azides; D004269:DNA, Bacterial; D016877:Oxidants; D030421:Peroxynitrous Acid; D014498:Uracil; D006997:Hypochlorous Acid; C010889:5-chlorouracil; D009195:Peroxidase